Tumor cells frequently acquire resistance to apoptosis through multiple mechanisms, including TP53 mutations, overexpression of anti-apoptotic BCL-2 family proteins, caspase inactivation, and metabolic rewiring, that enhance redox homeostasis. This evidence concerns the gene TP53 and neoplasm.